3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
|
1998
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
|
2021
|
|
Antiviral Program for Pandemics
|
Research Initiative
|
ASPR
|
NIAID, NCATS, OD/ DPCPSI/ ORIP
|
2020
|
|
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|
Assessment of task-based exposures that may affect reproductive health in nail salon employees
|
Research Initiative
|
CDC
|
|
2021
|
|
BARDA-DRIVe (DRIVE)
|
Research Initiative
|
ASPR
|
NIAID
|
2022
|
|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
|
2018
|
|
Biomarkers of Exposure and Effect in Agriculture (Water Contaminants)
|
Research Initiative
|
CDC
|
|
2019
|
|
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
|
Research Initiative
|
FDA
|
NIBIB
|
|
|
Botanical Safety Consortium
|
Research Initiative
|
FDA
|
NCCIH
|
2019
|
|
BRIDG Standard Development
|
Research Initiative
|
FDA
|
|
2004
|
|
Bridge to Artificial Intelligence (Bridge2AI)
|
Research Initiative
|
FDA
|
NLM, NEI, NHGRI, NCCIH, NIBIB, NICHD, NCATS, NIMH, NIMHD, NIAID, NCI, NIAMS, NINDS, NIDA, NIA, NIGMS, FIC, OD/ DPCPSI/ OBSSR, OD/ AoU, OD/ DPCPSI/ ODSS
|
2021
|
|
Cancer Moonshot Award
|
Research Initiative
|
OS
|
NCI, NIDCD
|
2019
|
|
CCR Vaccine Branch FACS Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CCR, LGI, Flow Cytometry Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CDC Pathogen Genomic Centers of Excellence (PGCoE)
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Cell-Surface Interactions in Pathogenesis
|
Research Initiative
|
FDA
|
NIDCR
|
|
|
Central Brain Tumor Registry of the United States (CBTRUS)
|
Research Initiative
|
CDC
|
|
2021
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/ DPCPSI/ OAR
|
2021
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
|
2018
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
2016
|
|
Clinical Trials of Biodefense Vaccines (Dengue)
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Combined Exposures and Mixtures Research Program
|
Research Initiative
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC, OD/ OIR
|
2004
|
|
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth
|
Research Initiative
|
CDC
|
|
2020
|
|
Coordinating Committee on Research on Women's Health (CCRWH) Sex, Gender, and Intersectionality (SG&I) Innovations Working Group (CCRWH SG&I Innovations WG)
|
Research Initiative
|
FDA, AHRQ, Other
|
OD, NIA, NHLBI, OD/ AoU, NIGMS, NICHD, NCI, NINDS, NIBIB, NCCIH, NIDA
|
2022
|
|
Countermeasures Against Chemical Threats program (CounterACT)
|
Research Initiative
|
ASPR
|
NIAID, NIAMS, NICHD, NEI, NINDS, NIDA
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya
|
Research Initiative
|
CDC
|
FIC, NIAID
|
2013
|
|
COVID antibody testing
|
Research Initiative
|
ASPR
|
NIAID
|
2020
|
|
COVID-19 and Influenza Scenario Modeling Hubs (SMH)
|
Research Initiative
|
CDC
|
NIGMS
|
2020
|
|
COVID-19 OpenData Portal
|
Research Initiative
|
ASPR
|
NCATS, NIAID, NLM
|
2020
|
|
Critical Path for Rare Neurodegenerative Diseases (CP-RND)
|
Research Initiative
|
FDA
|
|
2022
|
|
CURE ID
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
CURE ID App for Infectious Disease Case Reporting
|
Research Initiative
|
FDA
|
NCI
|
|
|
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Development testing of nucleic acid-based vaccine for HIV other indications
|
Research Initiative
|
FDA
|
NCI
|
|
|
Diabetes Prevention Program Outcomes Study (DPP/DPPOS)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NIA
|
1994
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
|
2011
|
|
Diet Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
|
2004
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
|
2011
|
|
EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite with Coordinating Center
|
Research Initiative
|
HRSA
|
NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
Ebola Clinical Research Response in Democratic Republic of the Congo
|
Research Initiative
|
CDC, ASPR
|
NIAID
|
2018
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
Emerging Contaminants and Issues of Concern Research Program
|
Research Initiative
|
CDC
|
NIEHS
|
|
|
Ending the HIV Epidemic in the US administrative supplement announcement for NIH Centers for AIDS Research and NIMH AIDS Research Centers
|
Research Initiative
|
CDC, HRSA, Other
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Environmental Phthalate Exposures In Pregnancy in Relation to Fetal and Placental Development
|
Research Initiative
|
CDC
|
|
2020
|
|
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Establishment of representative examination and dose repository for patients undergoing interventional fluoroscopic procedures
|
Research Initiative
|
FDA
|
|
2021
|
|
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO RGN)
|
Research Initiative
|
HRSA
|
NHGRI
|
2021
|
|
Evaluation of Oropharyngeal responses to SARS-CoV-2
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Evaluation of Visual Function in Animal Models
|
Research Initiative
|
FDA
|
NEI
|
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
|
2020
|
|
Federal Interagency Forum for Child and Family Statistics
|
Research Initiative
|
ACF, AHRQ, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH
|
2010
|
|
Federal Interagency Task Force on the Arts and Human Development
|
Research Initiative
|
ACF, ACL, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
FNIH Advanced Medicines Partnership® - Bespoke Gene Therapy Consortium (FNIH AMP BGTC)
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
FNIH Biomarkers Consortium (FNIH)
|
Research Initiative
|
CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS
|
2006
|
|
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Functional and Structural Optical Brain Imaging
|
Research Initiative
|
FDA
|
NICHD
|
|
|
FY 22 Ending the HIV Epidemic in the US Funding Opportunity Announcement
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIMH, NIDA
|
2022
|
|
Genetic Epidemiology of Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Genetic Epidemiology of Diabetic Complications
|
Research Initiative
|
IHS
|
|
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
2014
|
|
Genomic epidemiology of norovirus GII.4 globally
|
Research Initiative
|
FDA
|
|
2022
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Research Initiative
|
CDC
|
FIC, NCI, NIEHS, OD/ DPCPSI/ ORWH
|
2011
|
|
Global Substance Registration System (GSRS)
|
Research Initiative
|
FDA
|
NCATS, OD/ OIR
|
2013
|
|
Health and Retirement Study (HRS)
|
Research Initiative
|
CDC, CMS
|
NIA
|
1992
|
|
Helicobacter pylori Genome Project (HpGP)
|
Research Initiative
|
CDC
|
NLM
|
2016
|
|
Hepatitis B Research Network (HBRN)
|
Research Initiative
|
CDC
|
NCI, NIDDK
|
2008
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Coordination Operations and Response Element (previously Operation Warp Speed) (H-CORE/OWS)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
|
1992
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
|
2010
|
|
Host Immune Responses to Antigens of Malaria Parasites
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Human skin sensitization data set
|
Research Initiative
|
FDA
|
|
2020
|
|
Human Specimen Collection to Support Basic and Clinical Research
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Imaging Core Unit
|
Research Initiative
|
FDA
|
NEI
|
|
|
Immune Responses to Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Impact of Opioid-Related Emergencies on First Responders
|
Research Initiative
|
FDA
|
CC
|
|
|
Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National Ending the HIV Epidemic (EHE) Goals
|
Research Initiative
|
HRSA
|
NIDA
|
2020
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
In Silico Screening for Cancer Targets
|
Research Initiative
|
FDA
|
NCI
|
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
In Vitro Assessment of Respiratory Hypersensitivity: Using Alternative Methods to Predict Respiratory Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2022
|
|
Industrywide exposure assessment study of workers exposed to graphene and other two-dimensional nanomaterials
|
Research Initiative
|
CDC
|
NIEHS
|
2018
|
|
Influenza Viral Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inhibition Of Renal Injury
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Innovation Equity Forum Steering Committee (IEF SteerCo)
|
Research Initiative
|
FDA
|
OD, NICHD, NHLBI, NINDS, NIGMS, FIC, NCATS, NIA, NCCIH
|
2022
|
|
Integrated Research Facility at Fort Detrick
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations
|
Research Initiative
|
CDC
|
|
2004
|
|
Kidney Innovation Accelerator (KidneyX)
|
Research Initiative
|
FDA, OASH, ASPR
|
NCATS, NIBIB
|
2018
|
|
Laboratory Services Section, Department of Transfusion Medicine Core Report
|
Research Initiative
|
FDA
|
CC
|
|
|
Leveraging Novel Technologies for Chronic Disease Management for Aging Underserved Populations
|
Research Initiative
|
OASH
|
NHLBI
|
2020
|
|
Lupus Clinical Trials
|
Research Initiative
|
FDA
|
NIAMS
|
|
|
Macaque models for preclinical development of iPSCs
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Machine learning methods for literature data extraction
|
Research Initiative
|
FDA
|
|
2018
|
|
Magnetic Resonance Spectroscopy Core Facility
|
Research Initiative
|
FDA
|
NIMH
|
|
|
Mechanobiology
|
Research Initiative
|
FDA
|
NIBIB
|
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing (Tissue Chip for Drug Screening)
|
Research Initiative
|
FDA, ASPR
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC
|
2012
|
|
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Molecular approaches to understand vector-host and vector-pathogen interactions
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Molecular Immunohematology in Ethiopian Sub-populations
|
Research Initiative
|
FDA
|
CC
|
|
|
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Molecular Profiling of Diabetes and its Complications
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Mortality Disparities in American Communities (MDAC) Study
|
Research Initiative
|
CDC, FDA
|
NCI, NIA
|
1985
|
|
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Research Initiative
|
FDA
|
NINDS
|
|
|
Nanotechnology Characterization Laboratory (NCL)
|
Research Initiative
|
FDA
|
|
2004
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NICHD, NHLBI, NIDDK, FIC, NIAMS, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ONR, OD/ ECHO
|
2010
|
|
National COVID Cohort Collaborative (N3C)
|
Research Initiative
|
FDA, ASPR, CMS
|
NCATS, NIGMS
|
2021
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
|
|
|
National Neurological Conditions Surveillance System (NNCSS)
|
Research Initiative
|
CDC
|
NINDS
|
2016
|
|
National Robotics Initiative (NRI)
|
Research Initiative
|
CDC
|
NCATS, NEI, NIA, NIBIB, NINR, NICHD
|
2009
|
|
Native American Research Center for Health (NARCH)
|
Research Initiative
|
IHS
|
CSR, NCI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, NCCIH, NHGRI, NHLBI
|
2000
|
|
Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes (NEXT-D/NEXT-D 2.0/NEXT-D3)
|
Research Initiative
|
CDC
|
NIDDK
|
2010
|
|
NCHS-CDC NHANES, Dietary Supplements and Selected Nutritional Biomarkers
|
Research Initiative
|
CDC
|
|
1999
|
|
NCI Cervical Cancer "Last Mile" Initiative (LMI)
|
Research Initiative
|
FDA, CDC
|
|
2021
|
|
NCI Multi-Cancer Detection (MCD) Trial Team
|
Research Initiative
|
CMS, FDA
|
OD/ DPCPSI/ ORWH
|
2021
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
|
2015
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
|
2007
|
|
NF-kappaB in pathogenesis and therapy of head and neck cancer
|
Research Initiative
|
FDA
|
NICHD
|
|
|
NIA Confocal Imaging Facility
|
Research Initiative
|
FDA
|
NIA
|
|
|
NIA IMPACT Collaboratory Transforming Dementia Care (IMPACT Collaboratory)
|
Research Initiative
|
CDC
|
NIA
|
2019
|
|
NIMH-SAMHSA collaboration to support the delivery of evidence based practices in Certified Community Behavioral Health Clinic-Expansion (CCBHC-E) awardees
|
Research Initiative
|
SAMHSA
|
NIDA
|
2021
|
|
Nipah viral replicon particle vaccine safety & efficacy evaluation in NHP model
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Non-animal approaches to assess cardiotoxicity hazard
|
Research Initiative
|
FDA
|
|
2018
|
|
Noroviruses and Epidemic Gastroenteritis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services
|
Research Initiative
|
SAMHSA
|
|
2021
|
|
Novel Tools and Approaches Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
2018
|
|
Occupational Exposure Assessment of a-Pinene and related Monoterpenes
|
Research Initiative
|
CDC, FDA
|
|
2021
|
|
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
|
Research Initiative
|
CDC
|
NIEHS
|
2020
|
|
Office of the Clinical Director Clinical Services Research
|
Research Initiative
|
IHS
|
NIMH
|
|
|
Operation of the COVID-19 Treatment Guidelines Website
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
PALM007
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Pandemic Influenza Translational Research and novel universal countermeasure development
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pathophysiological Actions of Anthrax Virulence Determinants
|
Research Initiative
|
FDA
|
NIAID
|
|
|
PCORTF Frailty Functional Disabilities Project Working Group
|
Research Initiative
|
ASPE, AHRQ, CDC, CMS
|
|
2019
|
|
Physiological Effects of Natural or Contaminating Compounds in a Rodent's Microenvironment
|
Research Initiative
|
FDA
|
NIEHS
|
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Response Team
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Task Force
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Foundation
|
Research Initiative
|
CDC
|
CC
|
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
FIC, NCI, NIAAA, NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
Production and purification of biological compounds
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Quantitative Biophotonics for Tissue Characterization and Function
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic
|
Research Initiative
|
CDC
|
NIMHD
|
2021
|
|
Racial/Ethnic Variation of HPV Type Distribution in High-Grade Cervical Precancers and Invasive Cancers in the United States
|
Research Initiative
|
CDC
|
|
2016
|
|
Rapid Acceleration of Diagnostics Tech Program (RADx Tech)
|
Research Initiative
|
CMS, FDA, CDC, ASPR
|
NIBIB
|
2020
|
|
Rare Diseases Registry Program (RaDaR)
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Regenerative Medicine Project
|
Research Initiative
|
FDA
|
NIA
|
2017
|
|
Registry-based studies of hematologic malignancy incidence and survivorship
|
Research Initiative
|
FDA
|
|
2019
|
|
Regulation of Virulence Genes in Bordetella pertussis
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
RePORT South Africa
|
Research Initiative
|
CDC, OS
|
NIAID
|
2016
|
|
Research in Diabetes Mellitus, Its Complications, and Obesity
|
Research Initiative
|
IHS
|
|
1965
|
|
Research Operations Supporting the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
Retina Network
|
Research Initiative
|
OS
|
NEI, NIDDK
|
2002
|
|
Rheumatic and Autoimmune Diseases in Minority Communities
|
Research Initiative
|
FDA
|
NIAMS
|
|
|
Role of Class B Scavenger Receptors in Lipid Metabolism and Inflammation
|
Research Initiative
|
FDA
|
CC
|
|
|
Role of Gs-alpha in pancreatic islet cell growth and function
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Rural Opioid Initiative (ROI)
|
Research Initiative
|
CDC, SAMHSA
|
NIDA
|
2017
|
|
SARS-CoV-2 Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2 Virology Core
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
SEARCH for Diabetes in Youth (SEARCH)
|
Research Initiative
|
CDC
|
|
2001
|
|
Serum organochlorine/PCB concentrations and risk of prostate cancer in men from Ghana
|
Research Initiative
|
CDC
|
|
2022
|
|
Serum PFAS concentrations and risk of renal cell carcinoma in the Multiethnic Cohort
|
Research Initiative
|
CDC
|
|
2022
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ORIP, NIBIB, NEI, NICHD, NIDA, NIEHS
|
2017
|
|
Structural Analysis Of Candidate Genes For Type 2 Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Studies of the Natural History of Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Supporting Early Psychosis Research and Implementation
|
Research Initiative
|
OS, ASPE
|
|
2018
|
|
Systematic Evidence Review of Trauma Informed Care (TIC)
|
Research Initiative
|
AHRQ
|
|
2022
|
|
Systems Immunology of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Systems immunology of influenza vaccination responses in healthy COVID-19 recovered individual versus those with no history of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
2021
|
|
Taxonomics Methods Using DNA
|
Research Initiative
|
FDA
|
NLM
|
|
|
The Biology of HIV Infections
|
Research Initiative
|
FDA
|
NIAID
|
|
|
The contribution folate and vitamin B12 genes to disease.
|
Research Initiative
|
CDC
|
NHGRI
|
|
|
The Environmental Determinants of Diabetes in the Young (TEDDY)
|
Research Initiative
|
CDC
|
NIAID, NICHD, NIEHS, NIDDK
|
2002
|
|
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)
|
Research Initiative
|
CDC, FDA
|
NHGRI, NHLBI
|
2010
|
|
The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
|
Research Initiative
|
CDC
|
NIDDK, NHLBI
|
2016
|
|
The Golestan Cohort Study of Esophageal Cancer
|
Research Initiative
|
CDC
|
|
2018
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
|
2012
|
|
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
Research Initiative
|
CDC
|
|
1998
|
|
The NIH Helping to End Addiction Long Term (HEAL) Initiative
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NCATS, NCCIH, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ OSP, OD/ DPCPSI/ OBSSR
|
2018
|
|
The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL)
|
Research Initiative
|
CDC
|
NIAID
|
2014
|
|
The Role of the Scavenger Receptor B Family Proteins (SR-BI, SR-BII and CD36) in Infection and Sepsis
|
Research Initiative
|
FDA
|
CC
|
|
|
Therapies for patients with rare tumors and genetic tumor predisposition
|
Research Initiative
|
FDA
|
NCI
|
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
|
2016
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/ OER
|
2012
|
|
Toxicology in the 21st Century Federal Consortium: NCATS Interagency Agreement, ES-7020-01, Year 11 (Tox21)
|
Research Initiative
|
FDA
|
NIEHS, NCATS
|
2007
|
|
Toxicology in the 21st Century Program (Tox21) - Computational Toxicology
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Toxicology in the 21st Century Program (Tox21) - Systems Toxicology
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Tracking Resistance and Coronavirus Evolution (TRACE)
|
Research Initiative
|
ASPR, CDC, FDA
|
NCATS, NIAID
|
2021
|
|
Trans-HHS program for Multi-System Inflammatory Syndrome in Children (MIS-C) and pediatric SARS-CoV-2 (CARING)
|
Research Initiative
|
CDC, FDA, OASH
|
|
2020
|
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
|
2005
|
|
Trial to Assess Chelation Therapy 2 (TACT2)
|
Research Initiative
|
CDC
|
NCCIH, NHLBI, NIEHS, NIDDK
|
2016
|
|
Tribal Epidemiology Centers Program
|
Research Initiative
|
IHS, CDC
|
NIMHD, OD/ DPCPSI/ THRO
|
2002
|
|
Urine biomarkers and risk of lung cancer in the Sisters Study
|
Research Initiative
|
CDC, FDA
|
|
2019
|
|
Urine biomarkers of tobacco and opium and risk of cancers and heart disease
|
Research Initiative
|
CDC, FDA
|
|
2020
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
|
2019
|
|
Vaccines and Therapeutics for Anthrax
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Validation study of the electrophilic allergen screening assay
|
Research Initiative
|
FDA
|
|
2017
|
|
Vector-borne pathogen transmission
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Virus Ecology Unit
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Vision Research Collaborative
|
Research Initiative
|
FDA
|
NEI
|
2020
|
|
Weighting methods for healthy worker survivor bias
|
Research Initiative
|
CDC
|
|
2022
|
|
Whole Genome and Whole Exome Sequencing to Identify Genes for Type 2 Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
ZIA CARCI Carcinogenicity Health Effects innovation Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|